Applicant, as named in the Orange Book

Uswm

Next listed expiry: Iwilfin on 12 Feb 2036. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Iwilfin eflornithine hydrochloride	eflornithine hydrochloride	215500	12 Feb 2036	patent, carve-out possible